Evidence map›Paper›PMID 22306653›Full record

ArticleNature genetics2012

Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.

Dewi Astuti, Mark R Morris, Wendy N Cooper, Raymond H J Staals, Naomi C Wake, Graham A Fews, Harmeet Gill, Dean Gentle, Salwati Shuib, Christopher J Ricketts and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 2 syntheses or guidelines pooled it, 248 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Wilms tumor characteristics in children with heterozygous germline DIS3L2 variants.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Phenotypic Carney-Stratakis syndrome withProceedings (Baylor University. Medical Center) · 2025
    Article
  15. Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 4 countries.

Dewi AstutiCentre for Rare Diseases and Personalised Medicine, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, UK.
Mark R Morris
Wendy N Cooper
Raymond H J Staals
Naomi C Wake
Graham A Fews
Harmeet Gill
Dean Gentle
Salwati Shuib
Christopher J Ricketts
Trevor Cole
Anthonie J van Essen
Richard A van Lingen
Giovanni Neri
John M Opitz
Patrick Rump
Irene Stolte-Dijkstra
Ferenc Müller
Ger J M Pruijn
Farida Latif
Eamonn R Maher
University of Birmingham · GBBirmingham Women's Hospital · GBUniversity Medical Center Groningen · NLIsala · NLRadboud Institute for Molecular Life Sciences · NLRadboud University Medical Center · NLUniversità Cattolica del Sacro Cuore · ITUniversity of Groningen · NLUniversity of Utah · USUniversity of Wolverhampton · GB

Funding

Cancer Research UK C485/A5441Worldwide Cancer Research 07-0503
6 · The paper itself

Abstract

Perlman syndrome is a congenital overgrowth syndrome inherited in an autosomal recessive manner that is associated with Wilms tumor susceptibility. We mapped a previously unknown susceptibility locus to 2q37.1 and identified germline mutations in DIS3L2, a homolog of the Schizosaccharomyces pombe dis3 gene, in individuals with Perlman syndrome. Yeast dis3 mutant strains have mitotic abnormalities. Yeast Dis3 and its human homologs, DIS3 and DIS3L1, have exoribonuclease activity and bind to the core RNA exosome complex. DIS3L2 has a different intracellular localization and lacks the PIN domain found in DIS3 and DIS3L1; nevertheless, we show that DIS3L2 has exonuclease activity. DIS3L2 inactivation was associated with mitotic abnormalities and altered expression of mitotic checkpoint proteins. DIS3L2 overexpression suppressed the growth of human cancer cell lines, and knockdown enhanced the growth of these cells. We also detected evidence of DIS3L2 mutations in sporadic Wilms tumor. These observations suggest that DIS3L2 has a critical role in RNA metabolism and is essential for the regulation of cell growth and division.

Indexed as

AdolescentBase SequenceCell DivisionCell ProliferationChild, PreschoolChromosomes, Human, Pair 2ExoribonucleasesFetal MacrosomiaGene Expression RegulationGene Knockdown TechniquesGenes, cdcGenetic Predisposition to DiseaseGerm-Line MutationHeLa CellsHumansInfantDIS3L2 protein, humanExoribonucleasesRNA

Identifiers

PMID22306653
OpenAlexW2156679982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.